HIMA (Health Industry Manufacturers Association) sets up associate member status:

The Health Industry Manufacturers Association in the US has set up an associate membership category for professional service firms that might want to join the organisation. Associate members paying $10,000 annually will get access to the members-only portion of HIMA's website, invitations to member-only education programmes and discounts on seminars, conferences and exhibits. They will also be able to include detailed information about their company in the resource section of website. The trade group offers additional promotional and advertising opportunities to service firms that pay another $10,000 a year.

The Health Industry Manufacturers Association in the US has set up an associate membership category for professional service firms that might want to join the organisation. Associate members paying $10,000 annually will get access to the members-only portion of HIMA's website, invitations to member-only education programmes and discounts on seminars, conferences and exhibits. They will also be able to include detailed information about their company in the resource section of website. The trade group offers additional promotional and advertising opportunities to service firms that pay another $10,000 a year.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight

How Structured Patient Engagement Gives Medtech Companies A Competitive Edge

 

Communication with patients has become a particularly crucial factor for investors, payers, and other healthcare decision-makers in a hostile market environment.

Digital Health And AI Tools Advance Cardiac Event Prediction, SCAI 2025 Data Show

 
• By 

Out-of-hospital cardiac arrest remains one of the most challenging and resource-intensive emergencies in cardiovascular care. At SCAI 2025, clinicians presented a novel algorithm that improved triage decisions and reduced unnecessary interventions.

Debate On FDA User Fee Reauthorization Begins To Take Shape

 
• By 

A battle may be forming over the 2027 FDA user fee reauthorizations. At a conference Friday, Democratic Rep. Jake Auchincloss supports them for their effectiveness, while Deputy FDA Commissioner Grace Graham echoed criticisms from HHS Sec. Kennedy, among others, in calling for reform to ensure public trust.